Skip to content
Application 204726
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 4MG | No | No |
| 002 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 8MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0781-2623 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2623 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2623 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2623 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2623 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2624 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2624 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2624 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2624 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
| 0781-2624 | Silodosin | Silodosin | Sandoz Inc | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 47867 | ORIG | 2017-04-05 |